The FDA Completely Botched Its Response to the Baby Formula Shortage Plus: Resurrecting an extinct tiger, reviewing the police response to the Uvalde shooting, and more... Reason · May 27, 2022
FDA acknowledges slow response, 'suboptimal' decisions leading up to infant formula shortage WASHINGTON — Sluggish response and questionable decisions by the Food and Drug Administration exacerbated the nation's infant formula shortage, agency officials told lawmakers at a congressional hearing on Wednesday. Los Angeles Times · May 25, 2022
Millions of imported baby formula cans are heading to the US, FDA says Millions more cans of baby formula will be available in the U.S. in the coming months, the nation’s Food and Drug Administration said, detailing steps it’s taken to alleviate a shortage that has left families scrambling to figure out how to feed their babies. Tribune News Service · May 25, 2022
FDA chief to detail delays inspecting baby formula plant The head of the Food and Drug Administration is preparing to tell lawmakers about events that led to a months-long gap before inspecting the plant at the center of a nationwide baby formula shortage The Independent UK · May 25, 2022
Abbott baby formula factory could reopen by next week, FDA head says An Abbott baby formula plant in Michigan that’s been shut down since February could be up and running as early as next week, the head of the Food and Drug Administration told lawmakers Thursday. Tribune News Service · May 19, 2022
FDA head says baby formula factory could reopen in the next week or two But Abbott has said that, after production resumes, it could take about two months before new formula begins arriving in stores. The company's factory has been closed due to contamination problems. WEKU · May 19, 2022
Abbott's Troubled Baby Formula Michigan Plant To Reopen In 1-2 Weeks: Reuters Abbott Laboratories (NYSE:ABT) and the FDA are reportedly on track to reopen the company's Sturgis, Michigan, baby formula manufacturing plant within one or two weeks, FDA Commissioner Robert Califf said. Abbott, the biggest U.S. supplier of powder infant formula, including Similac, agreed with the FDA on the steps needed to resume production at… Benzinga · May 19, 2022
FDA: Infant formula supply will increase quickly - Roll Call The Biden administration says it will be 'a few weeks' before the baby food supply around the country is back to normal Roll Call · May 19, 2022
FDA faces congressional scrutiny over baby formula shortage The head of the Food and Drug Administration is facing congressional lawmakers for the first time over the national shortage of baby formula The Independent UK · May 19, 2022
How the U.S. got into this baby formula mess Just a handful of formula makers dominate the industry so a single plant shutdown can lead to empty shelves. WEKU · May 19, 2022
Despite Congress’ efforts, it’ll take time to refill the baby bottles WASHINGTON — Lawmakers are throwing nearly every tool in their arsenal, including a proposed $28 million in taxpayer dollars, at the baby formula shortage. But it isn’t clear how quickly those solutions will result in cans on grocery store shelves. Tribune News Service · May 18, 2022
Despite Congress’ efforts, it’ll take time to refill the baby bottles - Roll Call Lawmakers are scrambling to end the formula shortage, but experts say it will be months before families will feel an impact. Roll Call · May 18, 2022
Why is there a baby formula shortage in the US? With children hospitalised and parents paying up to $100 for a can, the president has now invoked a wartime measure to try to ensure there is enough formula to feed America’s babies The Independent UK · May 17, 2022
FDA announces plans to ease the shortage of baby formula Abbott, one of the largest formula-makers in the U.S., has reached an agreement with the government to bring a closed factory back on line. And the FDA is easing some restrictions on imported formula. WEKU · May 17, 2022
Tribune News Service · May 16, 2022 FDA chief says shuttered baby formula plant could reopen soon, offering hope to ease shortage The head of the Food and Drug Administration said Monday that a shuttered baby formula factory should reopen within two weeks, potentially easing a serious nationwide shortage.
The Independent UK · May 16, 2022 Biden offers logistics support to ease formula shortage President Joe Biden is offering formula manufacturers and retailers transportation and logistics support to ease the nationwide shortage of baby formula
Benzinga · May 16, 2022 Morning Brief: Top Financial Stories Dominating on Monday, May 16 CNBC Volkswagen CEO Shares Ambitious EV Ambitions For US Market
WEKU · May 13, 2022 White House bolsters efforts to get baby formula into the hands of WIC recipients States have been asked to increase accessibility of baby formula for recipients of the low-income program. And the Food and Drug Administration is looking at ways to make it easier to import formula.
Tribune News Service · May 13, 2022 Tainted baby-formula risk was seen months before Abbott’s recall Federal inspectors spotted the potential for baby formula made at an Abbott Laboratories plant to become contaminated months before a recall that exacerbated a nationwide shortage, a government document shows.
Axios · May 10, 2022 FDA says it is "doing everything in our power" to improve baby formula supply The shortage has intensified in recent weeks due to supply chain issues and a devastating recall.
Axios · May 2, 2022 Pressure builds for COVID vaccines approval for littlest kids Moderna's request for approval of its COVID -19 vaccine in children under six years amps up pressure on the Food and Drug Administration to act quickly to approve the shots.
Axios · Apr 28, 2022 FDA proposes ban on menthol cigarettes FDA commissioner Robert Califf said these rules "are appropriate for the protection of public health."
Tribune News Service · Apr 14, 2022 Outlook poses tough questions for next steps on COVID-19 vaccines Preparations for another potential round of COVID-19 vaccines are prompting more questions than answers as federal health officials contend with the threat of future variants amid waning public interest in additional shots.
Roll Call · Apr 13, 2022 Outlook poses tough questions for next steps on COVID-19 vaccines - Roll Call Health care officials face tough questions as they set policy to deal with the next phase of the pandemic and try to get the messaging right.
Reason · Mar 8, 2022 Can the FDA's New Commissioner Save the Agency From Itself? Robert Califf must demand transparency and accountability from the bureaucrats.